Craig Wheelock is Head of the Unit of Integrative Metabolomics in the 

Institute of Environmental Medicine at the Karolinska Institute (KI), where he serves as director of the Integrative Molecular Phenotyping Laboratory and the small molecule mass spectrometry core facility (KI-SMMS).

He is also a Distinguished Visiting Professor of Metabolomics at Gunma University, Japan. Following pre- and post-doctoral work on lipid mediators at the University of California Davis, he conducted post-doctoral studies at the KEGG laboratory in Kyoto University. In 2006, he was awarded a Marie Curie Fellowship to relocate to the KI. Research in his group focuses on molecular phenotyping of respiratory disease, with a particular interest in investigating the role of lipid mediators.

The overarching aim is to identify personalized molecular profiles that can be associated with an individual’s lifestyle, environmental exposure and susceptibility to asthma. He was a Board Member of the International Metabolomics Society from 2016-2020, a founding Board Member of the Nordic Metabolomics Society from 2017-2021, and currently serves on the Metabolomic Epidemiology Task Group as well as on the European Respiratory Society Advocacy Council as the Director of Scientific Relations with the EU. When not balancing his time between Sweden and Japan, he enjoys teaching his kids to kayak and paddling SUP with his dog.

Presentation

"Not just fat" – Exploring Octadecanoids as Novel Bioactive Lipids in Inflammation.